Banerjee, PoulomiElliott, ElizabethRifai, Olivia MO'shaughnessy, JudiMcDade, KarinaAbrahams, SharonChandran, SiddharthanSmith, ColinGregory, Jenna2022-07-082022-07-082022-03Banerjee, P, Elliott, E, Rifai, O M, O'shaughnessy, J, McDade, K, Abrahams, S, Chandran, S, Smith, C & Gregory, J 2022, 'NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis', The Journal of pathology, vol. 256, pp. 262-268. https://doi.org/10.1002/path.58460022-3417ORCID: /0000-0003-3337-4079/work/112143940https://hdl.handle.net/2164/18827Funding Pathological Society of Great Britain and Ireland. Grant Number: Jean Shanks Foundation Clinical Lecturer Support G OR is funded by a Wellcome Trust PhD fellowship (108890/Z/15/Z). JMG is funded by a starter grant for clinical lecturers from the AMS (210JMG 3102 R45620) and a Clinical Lecturer Support Grant from The Pathological Society/Jean Shanks Foundation, and brain bank funding from the MRC (MR/L016400/1). EE is funded by a PhD fellowship from the CSO and MND Scotland: 217ARF R45951.718950650engcognitionamyotrophic lateral sclerosis;NLRP3 inflammasomeinterleukin 6nterleukin 10SIRT2RC0321 Neuroscience. Biological psychiatry. NeuropsychiatryWellcome Trust108890/Z/15/ZOther210JMG 3102 R45620Medical Research Council (MRC)MR/L016400/1Chief Scientist Office (CSO)217ARF R45951Supplementary DataRC0321NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosisJournal article10.1002/path.5846http://dx.doi.org/10.1002/path.5846http://www.scopus.com/inward/record.url?scp=85122315747&partnerID=8YFLogxK256